English

HUBEI MINKANG PHARMACEUTICAL LTD.

EDGAR

HBMK Quarterly report (10-Q) · filed 2014-11-14

39 filing records in this dataset, filed from 2006-11-27 to 2014-11-14. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

2.01 million USD

2015 Q2 · USD

Exact inputs and evidence

Revenue: 2012626 USD Source

Operating margin

-0.99%

2015 Q2 · %

Exact inputs and evidence

Operating Income: -19842 USD Source
Revenue: 2012626 USD Source

Operating cash flow

-841 thousand USD

2015 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -1394468 USD Source
Operating Cash Flow: -553885 USD Source

Cash and cash equivalents: 6.23 million USD 2013-12-31 Source
Exact value

6234193 USD
Long-term debt including current maturities: Not available
Shares outstanding: 52.2 million shares 2014-09-30 Source
Exact value

52189045 shares

Reported share-count change

0.00% · 0 shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

52189045 shares · 2013-09-30· Source
52189045 shares · 2014-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

10.3 million USD

2013-10-01 – 2014-09-30

Exact inputs and evidence

Revenue: 14742964 USD · 2013-01-01 – 2013-12-31 Source
Revenue: 10991479 USD · 2013-01-01 – 2013-09-30 Source
Revenue: 2885436 USD · 2014-01-01 – 2014-03-31 Source
Revenue: 1681211 USD · 2014-04-01 – 2014-06-30 Source
Revenue: 2012626 USD · 2014-07-01 – 2014-09-30 Source

Net income

-961 thousand USD

2013-10-01 – 2014-09-30

Exact inputs and evidence

Net income: 127268 USD · 2013-01-01 – 2013-12-31 Source
Net income: 355581 USD · 2013-01-01 – 2013-09-30 Source
Net income: -82284 USD · 2014-01-01 – 2014-03-31 Source
Net income: -645072 USD · 2014-04-01 – 2014-06-30 Source
Net income: -5269 USD · 2014-07-01 – 2014-09-30 Source

Operating cash flow

-805 thousand USD

2013-10-01 – 2014-09-30

Exact inputs and evidence

Operating cash flow: 913110 USD · 2013-01-01 – 2013-12-31 Source
Operating cash flow: 323741 USD · 2013-01-01 – 2013-09-30 Source
Operating cash flow: -888578 USD · 2014-01-01 – 2014-03-31 Source
Operating cash flow: -553885 USD · 2014-01-01 – 2014-06-30 Source
Operating cash flow: -888578 USD · 2014-01-01 – 2014-03-31 Source
Operating cash flow: -1394468 USD · 2014-01-01 – 2014-09-30 Source
Operating cash flow: -553885 USD · 2014-01-01 – 2014-06-30 Source

Capital expenditure

352 thousand USD

2012-10-01 – 2013-09-30

Exact inputs and evidence

Capital expenditure: 385102 USD · 2012-01-01 – 2012-12-31 Source
Capital expenditure: 250513 USD · 2012-01-01 – 2012-09-30 Source
Capital expenditure: 40619 USD · 2013-01-01 – 2013-03-31 Source
Capital expenditure: 166466 USD · 2013-01-01 – 2013-06-30 Source
Capital expenditure: 40619 USD · 2013-01-01 – 2013-03-31 Source
Capital expenditure: 217554 USD · 2013-01-01 – 2013-09-30 Source
Capital expenditure: 166466 USD · 2013-01-01 – 2013-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2014-11-14.

Financial data available through: 2013-12-31.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2013-12-31
Operating income: 4 of 11 periods available· newest 2013-12-31
Net income: 9 of 11 periods available· newest 2013-12-31
Operating cash flow: 4 of 11 periods available· newest 2013-12-31
Capital expenditure: 4 of 11 periods available· newest 2013-12-31
Total assets: 4 of 11 periods available· newest 2013-12-31
Total liabilities: 4 of 11 periods available· newest 2013-12-31
Current assets: 4 of 11 periods available· newest 2013-12-31
Current liabilities: 4 of 11 periods available· newest 2013-12-31
Cash and cash equivalents: 4 of 11 periods available· newest 2013-12-31
long term debt: No compatible figures in this window
Shares outstanding: 4 of 11 periods available· newest 2013-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+5.9%

Prior period

USD 13.92 million

2012-01-01 – 2012-12-31
Current period

USD 14.74 million

2013-01-01 – 2013-12-31

Exact inputs and evidence

14742964 − 13918655 = 824309 USD

13918655 USD · 2012-01-01 – 2012-12-31
Inspect prior input Prior source
14742964 USD · 2013-01-01 – 2013-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · HUBEI MINKANG PHARMACEUTICAL LTD. · 2013-12-31 HUBEI MINKANG PHARMACEUTICAL LTD. (edgar:1375850) Year-over-year change in Revenue: 824309 USD Concept: fundies:Revenue Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T07:48:01Z Snapshot: f35027420f48431c2d53b70dda8d0adb81d3c14238c4caa43e86e2439d9e625c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375850?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 14742964 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000147793214001798/hbmk-20131231.xml#73484 Filing: 000147793214001798 Input fundies:Revenue: 13918655 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000147793214001798/hbmk-20131231.xml#73609 Filing: 000147793214001798
The citation records this snapshot. The page link may show a newer release later.
Net income
-86.8%

Prior period

USD 961,120

2012-01-01 – 2012-12-31
Current period

USD 127,268

2013-01-01 – 2013-12-31

Exact inputs and evidence

127268 − 961120 = -833852 USD

961120 USD · 2012-01-01 – 2012-12-31
Inspect prior input Prior source
127268 USD · 2013-01-01 – 2013-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · HUBEI MINKANG PHARMACEUTICAL LTD. · 2013-12-31 HUBEI MINKANG PHARMACEUTICAL LTD. (edgar:1375850) Year-over-year change in Net income: -833852 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T07:48:01Z Snapshot: f35027420f48431c2d53b70dda8d0adb81d3c14238c4caa43e86e2439d9e625c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375850?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 127268 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000147793214006259/hbmk-20140930.xml#81715 Filing: 000147793214006259 Input fundies:NetIncome: 961120 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000147793214001798/hbmk-20131231.xml#46234 Filing: 000147793214001798
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-54.5%

Prior period

USD 2.01 million

2012-01-01 – 2012-12-31
Current period

USD 913,110

2013-01-01 – 2013-12-31

Exact inputs and evidence

913110 − 2005050 = -1091940 USD

2005050 USD · 2012-01-01 – 2012-12-31
Inspect prior input Prior source
913110 USD · 2013-01-01 – 2013-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · HUBEI MINKANG PHARMACEUTICAL LTD. · 2013-12-31 HUBEI MINKANG PHARMACEUTICAL LTD. (edgar:1375850) Year-over-year change in Operating cash flow: -1091940 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T07:48:01Z Snapshot: f35027420f48431c2d53b70dda8d0adb81d3c14238c4caa43e86e2439d9e625c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375850?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 913110 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000147793214001798/hbmk-20131231.xml#79715 Filing: 000147793214001798 Input fundies:OperatingCashFlow: 2005050 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000147793214001798/hbmk-20131231.xml#79906 Filing: 000147793214001798
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-46.9%

Prior period

USD 385,102

2012-01-01 – 2012-12-31
Current period

USD 204,593

2013-01-01 – 2013-12-31

Exact inputs and evidence

204593 − 385102 = -180509 USD

385102 USD · 2012-01-01 – 2012-12-31
Inspect prior input Prior source
204593 USD · 2013-01-01 – 2013-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · HUBEI MINKANG PHARMACEUTICAL LTD. · 2013-12-31 HUBEI MINKANG PHARMACEUTICAL LTD. (edgar:1375850) Year-over-year change in Capital expenditure: -180509 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T07:48:01Z Snapshot: f35027420f48431c2d53b70dda8d0adb81d3c14238c4caa43e86e2439d9e625c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375850?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 204593 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000147793214001798/hbmk-20131231.xml#85125 Filing: 000147793214001798 Input fundies:CapitalExpenditure: 385102 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000147793214001798/hbmk-20131231.xml#85316 Filing: 000147793214001798
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2014 2013-01-01 – 2013-12-31

Revenue USD 14.74 million 100% of revenue
Operating costs Derived USD 14.7 million 100% of revenue
Operating income USD 41,953 0.3% of revenue
Tax, interest and other Derived −USD 85,315 −0.6% of revenue
Net income USD 127,268 0.9% of revenue

Cash

Operating cash flow USD 913,110 6.2% of revenue
Capital expenditure USD 204,593 1.4% of revenue
Free cash flow Derived USD 708,517 4.8% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2011 15%77%
2012 Net loss: net income was −1.7% of revenue.
2013 93%
2014 Net income was higher than operating income, so the split is not drawn.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2011 2010-01-01 – 2010-12-31	15010863	11530179 Derived	3480684	1276253 Derived	2204431	3434297 Derived	Source 2010-01-01 – 2010-12-31: 15010863 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: 3480684 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: 2204431 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: 3681203 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 246906 USD Inspect Capital Expenditure Open source
2012 2011-01-01 – 2011-12-31	12551511	11927103 Derived	624408	838453 Derived	-214045	-1066928 Derived	Source 2011-01-01 – 2011-12-31: 12551511 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: 624408 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -214045 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: -746813 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 320115 USD Inspect Capital Expenditure Open source
2013 2012-01-01 – 2012-12-31	13918655	12894341 Derived	1024314	63194 Derived	961120	1619948 Derived	Source 2012-01-01 – 2012-12-31: 13918655 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: 1024314 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: 961120 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: 2005050 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 385102 USD Inspect Capital Expenditure Open source
2014 2013-01-01 – 2013-12-31	14742964	14701011 Derived	41953	-85315 Derived	127268	708517 Derived	Source 2013-01-01 – 2013-12-31: 14742964 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: 41953 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: 127268 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: 913110 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 204593 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 14.7M 2014

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20112010-12-31	Revenue	15010863	Revenue: 15010863 Open source
20122011-12-31	Revenue	12551511	Revenue: 12551511 Open source
20132012-12-31	Revenue	13918655	Revenue: 13918655 Open source
20142013-12-31	Revenue	14742964	Revenue: 14742964 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

5.9% 2014

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20112010-12-31	Year over year	No prior comparable period	Revenue: 15010863 Open source
20122011-12-31	Year over year	-16.4%	Revenue: 12551511 Open source Revenue: 15010863 Open source
20132012-12-31	Year over year	10.9%	Revenue: 13918655 Open source Revenue: 12551511 Open source
20142013-12-31	Year over year	5.9%	Revenue: 14742964 Open source Revenue: 13918655 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 0.3% 2014

Net margin 0.9% 2014

Free cash flow margin 4.8% 2014

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20112010-12-31	Operating margin	23.2%	Operating Income: 3480684 Open source Revenue: 15010863 Open source
20122011-12-31	Operating margin	5%	Operating Income: 624408 Open source Revenue: 12551511 Open source
20132012-12-31	Operating margin	7.4%	Operating Income: 1024314 Open source Revenue: 13918655 Open source
20142013-12-31	Operating margin	0.3%	Operating Income: 41953 Open source Revenue: 14742964 Open source
20112010-12-31	Net margin	14.7%	Net Income: 2204431 Open source Revenue: 15010863 Open source
20122011-12-31	Net margin	-1.7%	Net Income: -214045 Open source Revenue: 12551511 Open source
20132012-12-31	Net margin	6.9%	Net Income: 961120 Open source Revenue: 13918655 Open source
20142013-12-31	Net margin	0.9%	Net Income: 127268 Open source Revenue: 14742964 Open source
20112010-12-31	Free cash flow margin	22.9%	Revenue: 15010863 Open source Operating Cash Flow: 3681203 Open source Capital Expenditure: 246906 Open source
20122011-12-31	Free cash flow margin	-8.5%	Revenue: 12551511 Open source Operating Cash Flow: -746813 Open source Capital Expenditure: 320115 Open source
20132012-12-31	Free cash flow margin	11.6%	Revenue: 13918655 Open source Operating Cash Flow: 2005050 Open source Capital Expenditure: 385102 Open source
20142013-12-31	Free cash flow margin	4.8%	Revenue: 14742964 Open source Operating Cash Flow: 913110 Open source Capital Expenditure: 204593 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 913.1K 2014

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20112010-12-31	Operating cash flow	3681203	Operating Cash Flow: 3681203 Open source
20122011-12-31	Operating cash flow	-746813	Operating Cash Flow: -746813 Open source
20132012-12-31	Operating cash flow	2005050	Operating Cash Flow: 2005050 Open source
20142013-12-31	Operating cash flow	913110	Operating Cash Flow: 913110 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 708.5K 2014

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20112010-12-31	Free cash flow	3434297	Operating Cash Flow: 3681203 Open source Capital Expenditure: 246906 Open source
20122011-12-31	Free cash flow	-1066928	Operating Cash Flow: -746813 Open source Capital Expenditure: 320115 Open source
20132012-12-31	Free cash flow	1619948	Operating Cash Flow: 2005050 Open source Capital Expenditure: 385102 Open source
20142013-12-31	Free cash flow	708517	Operating Cash Flow: 913110 Open source Capital Expenditure: 204593 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

47.1% 2014

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20112010-12-31	Liabilities / assets	47.9%	Total Liabilities: 6955167 Open source Total Assets: 14533099 Open source
20122011-12-31	Liabilities / assets	57.8%	Total Liabilities: 10323759 Open source Total Assets: 17853726 Open source
20132012-12-31	Liabilities / assets	46.5%	Total Liabilities: 9538399 Open source Total Assets: 20491416 Open source
20142013-12-31	Liabilities / assets	47.1%	Total Liabilities: 10187785 Open source Total Assets: 21615120 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.43× 2014

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20112010-12-31	Current assets / current liabilities	1.03×	Current Assets: 7197228 Open source Current Liabilities: 6955167 Open source
20122011-12-31	Current assets / current liabilities	1.01×	Current Assets: 10442885 Open source Current Liabilities: 10323759 Open source
20132012-12-31	Current assets / current liabilities	1.38×	Current Assets: 13198632 Open source Current Liabilities: 9538399 Open source
20142013-12-31	Current assets / current liabilities	1.43×	Current Assets: 14599201 Open source Current Liabilities: 10187785 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2007 2006-04-17 – 2007-03-31	−USD 81,059 Exact value Exact value: -81059 USD 2006-04-17 – 2007-03-31: -81059 USD Inspect Net Income Open source Share or cite Citation for Net Income · HUBEI MINKANG PHARMACEUTICAL LTD. · 2007-03-31 HUBEI MINKANG PHARMACEUTICAL LTD. (edgar:1375850) Net Income: -81059 USD Concept: fundies:NetIncome Period: 2006-04-17 to 2007-03-31 Values: Latest reported Published: 2026-11-02T07:48:01Z Snapshot: f35027420f48431c2d53b70dda8d0adb81d3c14238c4caa43e86e2439d9e625c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375850/explain?concept=fundies%3ANetIncome&period=2007-03-31&surface=latest&period_type=duration&start=2006-04-17&unit=USD&dimensions= Input fundies:NetIncome: -81059 USD (2006-04-17 to 2007-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000114420411052825/hbmk-20110630.xml#18214 Filing: 000114420411052825 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2008 2007-04-01 – 2008-03-31	−USD 128,230 Exact value Exact value: -128230 USD 2007-04-01 – 2008-03-31: -128230 USD Inspect Net Income Open source Share or cite Citation for Net Income · HUBEI MINKANG PHARMACEUTICAL LTD. · 2008-03-31 HUBEI MINKANG PHARMACEUTICAL LTD. (edgar:1375850) Net Income: -128230 USD Concept: fundies:NetIncome Period: 2007-04-01 to 2008-03-31 Values: Latest reported Published: 2026-11-02T07:48:01Z Snapshot: f35027420f48431c2d53b70dda8d0adb81d3c14238c4caa43e86e2439d9e625c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375850/explain?concept=fundies%3ANetIncome&period=2008-03-31&surface=latest&period_type=duration&start=2007-04-01&unit=USD&dimensions= Input fundies:NetIncome: -128230 USD (2007-04-01 to 2008-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000114420411052825/hbmk-20110630.xml#27592 Filing: 000114420411052825 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2009 2008-04-01 – 2009-03-31	−USD 199,588 Exact value Exact value: -199588 USD 2008-04-01 – 2009-03-31: -199588 USD Inspect Net Income Open source Share or cite Citation for Net Income · HUBEI MINKANG PHARMACEUTICAL LTD. · 2009-03-31 HUBEI MINKANG PHARMACEUTICAL LTD. (edgar:1375850) Net Income: -199588 USD Concept: fundies:NetIncome Period: 2008-04-01 to 2009-03-31 Values: Latest reported Published: 2026-11-02T07:48:01Z Snapshot: f35027420f48431c2d53b70dda8d0adb81d3c14238c4caa43e86e2439d9e625c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375850/explain?concept=fundies%3ANetIncome&period=2009-03-31&surface=latest&period_type=duration&start=2008-04-01&unit=USD&dimensions= Input fundies:NetIncome: -199588 USD (2008-04-01 to 2009-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000114420411052825/hbmk-20110630.xml#19965 Filing: 000114420411052825 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2010 2009-04-01 – 2010-03-31	−USD 1.83 million Exact value Exact value: -1831371 USD 2009-04-01 – 2010-03-31: -1831371 USD Inspect Net Income Open source Share or cite Citation for Net Income · HUBEI MINKANG PHARMACEUTICAL LTD. · 2010-03-31 HUBEI MINKANG PHARMACEUTICAL LTD. (edgar:1375850) Net Income: -1831371 USD Concept: fundies:NetIncome Period: 2009-04-01 to 2010-03-31 Values: Latest reported Published: 2026-11-02T07:48:01Z Snapshot: f35027420f48431c2d53b70dda8d0adb81d3c14238c4caa43e86e2439d9e625c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375850/explain?concept=fundies%3ANetIncome&period=2010-03-31&surface=latest&period_type=duration&start=2009-04-01&unit=USD&dimensions= Input fundies:NetIncome: -1831371 USD (2009-04-01 to 2010-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000114420411052825/hbmk-20110630.xml#23553 Filing: 000114420411052825 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2011 2010-01-01 – 2010-12-31	USD 2.2 million Exact value Exact value: 2204431 USD 2010-01-01 – 2010-12-31: 2204431 USD Inspect Net Income Open source Share or cite Citation for Net Income · HUBEI MINKANG PHARMACEUTICAL LTD. · 2010-12-31 HUBEI MINKANG PHARMACEUTICAL LTD. (edgar:1375850) Net Income: 2204431 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T07:48:01Z Snapshot: f35027420f48431c2d53b70dda8d0adb81d3c14238c4caa43e86e2439d9e625c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375850/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: 2204431 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000114420412030544/hbmk-20120331.xml#28649 Filing: 000114420412030544 The citation records this snapshot. The page link may show a newer release later.	USD 3.68 million Exact value Exact value: 3681203 USD 2010-01-01 – 2010-12-31: 3681203 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HUBEI MINKANG PHARMACEUTICAL LTD. · 2010-12-31 HUBEI MINKANG PHARMACEUTICAL LTD. (edgar:1375850) Operating Cash Flow: 3681203 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T07:48:01Z Snapshot: f35027420f48431c2d53b70dda8d0adb81d3c14238c4caa43e86e2439d9e625c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375850/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 3681203 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000114420412025841/hbmk-20111231.xml#28566 Filing: 000114420412025841 The citation records this snapshot. The page link may show a newer release later.	USD 246,906 Exact value Exact value: 246906 USD 2010-01-01 – 2010-12-31: 246906 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HUBEI MINKANG PHARMACEUTICAL LTD. · 2010-12-31 HUBEI MINKANG PHARMACEUTICAL LTD. (edgar:1375850) Capital Expenditure: 246906 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T07:48:01Z Snapshot: f35027420f48431c2d53b70dda8d0adb81d3c14238c4caa43e86e2439d9e625c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375850/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 246906 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000114420412025841/hbmk-20111231.xml#32451 Filing: 000114420412025841 The citation records this snapshot. The page link may show a newer release later.	USD 3.43 million Calculation and evidence 3681203 − 246906 USD Exact free cash flow: 3434297 USD 2010-01-01 – 2010-12-31: 3681203 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 246906 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HUBEI MINKANG PHARMACEUTICAL LTD. · 2010-12-31 HUBEI MINKANG PHARMACEUTICAL LTD. (edgar:1375850) Free cash flow: 3434297 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T07:48:01Z Snapshot: f35027420f48431c2d53b70dda8d0adb81d3c14238c4caa43e86e2439d9e625c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375850?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 3681203 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000114420412025841/hbmk-20111231.xml#28566 Filing: 000114420412025841 Input fundies:CapitalExpenditure: 246906 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000114420412025841/hbmk-20111231.xml#32451 Filing: 000114420412025841 The citation records this snapshot. The page link may show a newer release later.
2011 2010-04-01 – 2011-03-31	−USD 768,816 Exact value Exact value: -768816 USD 2010-04-01 – 2011-03-31: -768816 USD Inspect Net Income Open source Share or cite Citation for Net Income · HUBEI MINKANG PHARMACEUTICAL LTD. · 2011-03-31 HUBEI MINKANG PHARMACEUTICAL LTD. (edgar:1375850) Net Income: -768816 USD Concept: fundies:NetIncome Period: 2010-04-01 to 2011-03-31 Values: Latest reported Published: 2026-11-02T07:48:01Z Snapshot: f35027420f48431c2d53b70dda8d0adb81d3c14238c4caa43e86e2439d9e625c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375850/explain?concept=fundies%3ANetIncome&period=2011-03-31&surface=latest&period_type=duration&start=2010-04-01&unit=USD&dimensions= Input fundies:NetIncome: -768816 USD (2010-04-01 to 2011-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000114420411052825/hbmk-20110630.xml#24291 Filing: 000114420411052825 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2012 2011-01-01 – 2011-12-31	−USD 214,045 Exact value Exact value: -214045 USD 2011-01-01 – 2011-12-31: -214045 USD Inspect Net Income Open source Share or cite Citation for Net Income · HUBEI MINKANG PHARMACEUTICAL LTD. · 2011-12-31 HUBEI MINKANG PHARMACEUTICAL LTD. (edgar:1375850) Net Income: -214045 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T07:48:01Z Snapshot: f35027420f48431c2d53b70dda8d0adb81d3c14238c4caa43e86e2439d9e625c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375850/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -214045 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000135448813002122/hbmk-20121231.xml#66848 Filing: 000135448813002122 The citation records this snapshot. The page link may show a newer release later.	−USD 746,813 Exact value Exact value: -746813 USD 2011-01-01 – 2011-12-31: -746813 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HUBEI MINKANG PHARMACEUTICAL LTD. · 2011-12-31 HUBEI MINKANG PHARMACEUTICAL LTD. (edgar:1375850) Operating Cash Flow: -746813 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T07:48:01Z Snapshot: f35027420f48431c2d53b70dda8d0adb81d3c14238c4caa43e86e2439d9e625c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375850/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -746813 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000135448813002122/hbmk-20121231.xml#84243 Filing: 000135448813002122 The citation records this snapshot. The page link may show a newer release later.	USD 320,115 Exact value Exact value: 320115 USD 2011-01-01 – 2011-12-31: 320115 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HUBEI MINKANG PHARMACEUTICAL LTD. · 2011-12-31 HUBEI MINKANG PHARMACEUTICAL LTD. (edgar:1375850) Capital Expenditure: 320115 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T07:48:01Z Snapshot: f35027420f48431c2d53b70dda8d0adb81d3c14238c4caa43e86e2439d9e625c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375850/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 320115 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000135448813002122/hbmk-20121231.xml#85010 Filing: 000135448813002122 The citation records this snapshot. The page link may show a newer release later.	−USD 1.07 million Calculation and evidence -746813 − 320115 USD Exact free cash flow: -1066928 USD 2011-01-01 – 2011-12-31: -746813 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 320115 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HUBEI MINKANG PHARMACEUTICAL LTD. · 2011-12-31 HUBEI MINKANG PHARMACEUTICAL LTD. (edgar:1375850) Free cash flow: -1066928 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T07:48:01Z Snapshot: f35027420f48431c2d53b70dda8d0adb81d3c14238c4caa43e86e2439d9e625c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375850?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -746813 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000135448813002122/hbmk-20121231.xml#84243 Filing: 000135448813002122 Input fundies:CapitalExpenditure: 320115 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000135448813002122/hbmk-20121231.xml#85010 Filing: 000135448813002122 The citation records this snapshot. The page link may show a newer release later.
2013 2012-01-01 – 2012-12-31	USD 961,120 Exact value Exact value: 961120 USD 2012-01-01 – 2012-12-31: 961120 USD Inspect Net Income Open source Share or cite Citation for Net Income · HUBEI MINKANG PHARMACEUTICAL LTD. · 2012-12-31 HUBEI MINKANG PHARMACEUTICAL LTD. (edgar:1375850) Net Income: 961120 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T07:48:01Z Snapshot: f35027420f48431c2d53b70dda8d0adb81d3c14238c4caa43e86e2439d9e625c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375850/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: 961120 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000147793214001798/hbmk-20131231.xml#46234 Filing: 000147793214001798 The citation records this snapshot. The page link may show a newer release later.	USD 2.01 million Exact value Exact value: 2005050 USD 2012-01-01 – 2012-12-31: 2005050 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HUBEI MINKANG PHARMACEUTICAL LTD. · 2012-12-31 HUBEI MINKANG PHARMACEUTICAL LTD. (edgar:1375850) Operating Cash Flow: 2005050 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T07:48:01Z Snapshot: f35027420f48431c2d53b70dda8d0adb81d3c14238c4caa43e86e2439d9e625c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375850/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 2005050 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000147793214001798/hbmk-20131231.xml#79906 Filing: 000147793214001798 The citation records this snapshot. The page link may show a newer release later.	USD 385,102 Exact value Exact value: 385102 USD 2012-01-01 – 2012-12-31: 385102 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HUBEI MINKANG PHARMACEUTICAL LTD. · 2012-12-31 HUBEI MINKANG PHARMACEUTICAL LTD. (edgar:1375850) Capital Expenditure: 385102 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T07:48:01Z Snapshot: f35027420f48431c2d53b70dda8d0adb81d3c14238c4caa43e86e2439d9e625c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375850/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 385102 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000147793214001798/hbmk-20131231.xml#85316 Filing: 000147793214001798 The citation records this snapshot. The page link may show a newer release later.	USD 1.62 million Calculation and evidence 2005050 − 385102 USD Exact free cash flow: 1619948 USD 2012-01-01 – 2012-12-31: 2005050 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 385102 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HUBEI MINKANG PHARMACEUTICAL LTD. · 2012-12-31 HUBEI MINKANG PHARMACEUTICAL LTD. (edgar:1375850) Free cash flow: 1619948 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T07:48:01Z Snapshot: f35027420f48431c2d53b70dda8d0adb81d3c14238c4caa43e86e2439d9e625c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375850?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 2005050 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000147793214001798/hbmk-20131231.xml#79906 Filing: 000147793214001798 Input fundies:CapitalExpenditure: 385102 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000147793214001798/hbmk-20131231.xml#85316 Filing: 000147793214001798 The citation records this snapshot. The page link may show a newer release later.
2014 2013-01-01 – 2013-12-31	USD 127,268 Exact value Exact value: 127268 USD 2013-01-01 – 2013-12-31: 127268 USD Inspect Net Income Open source Share or cite Citation for Net Income · HUBEI MINKANG PHARMACEUTICAL LTD. · 2013-12-31 HUBEI MINKANG PHARMACEUTICAL LTD. (edgar:1375850) Net Income: 127268 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T07:48:01Z Snapshot: f35027420f48431c2d53b70dda8d0adb81d3c14238c4caa43e86e2439d9e625c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375850/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: 127268 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000147793214006259/hbmk-20140930.xml#81715 Filing: 000147793214006259 The citation records this snapshot. The page link may show a newer release later.	USD 913,110 Exact value Exact value: 913110 USD 2013-01-01 – 2013-12-31: 913110 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HUBEI MINKANG PHARMACEUTICAL LTD. · 2013-12-31 HUBEI MINKANG PHARMACEUTICAL LTD. (edgar:1375850) Operating Cash Flow: 913110 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T07:48:01Z Snapshot: f35027420f48431c2d53b70dda8d0adb81d3c14238c4caa43e86e2439d9e625c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375850/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 913110 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000147793214001798/hbmk-20131231.xml#79715 Filing: 000147793214001798 The citation records this snapshot. The page link may show a newer release later.	USD 204,593 Exact value Exact value: 204593 USD 2013-01-01 – 2013-12-31: 204593 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HUBEI MINKANG PHARMACEUTICAL LTD. · 2013-12-31 HUBEI MINKANG PHARMACEUTICAL LTD. (edgar:1375850) Capital Expenditure: 204593 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T07:48:01Z Snapshot: f35027420f48431c2d53b70dda8d0adb81d3c14238c4caa43e86e2439d9e625c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375850/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 204593 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000147793214001798/hbmk-20131231.xml#85125 Filing: 000147793214001798 The citation records this snapshot. The page link may show a newer release later.	USD 708,517 Calculation and evidence 913110 − 204593 USD Exact free cash flow: 708517 USD 2013-01-01 – 2013-12-31: 913110 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 204593 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HUBEI MINKANG PHARMACEUTICAL LTD. · 2013-12-31 HUBEI MINKANG PHARMACEUTICAL LTD. (edgar:1375850) Free cash flow: 708517 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T07:48:01Z Snapshot: f35027420f48431c2d53b70dda8d0adb81d3c14238c4caa43e86e2439d9e625c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375850?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 913110 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000147793214001798/hbmk-20131231.xml#79715 Filing: 000147793214001798 Input fundies:CapitalExpenditure: 204593 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375850/000147793214001798/hbmk-20131231.xml#85125 Filing: 000147793214001798 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

39 filings · 1,172 latest values · 1,165 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001375850, 1375850, HBMK, edgar:1375850

Also known as BLACKROCK PETROLEUM CORP., DGT Corp., HUBEI MINKANG PHARMACEUTICAL LTD., Hubei Minkang Pharmaceutical Ltd., Nexgen Petroleum Corp.

HUBEI MINKANG PHARMACEUTICAL LTD.

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2014 2013-01-01 – 2013-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation